Emerging markets hold promise for pharma sales

08/24/2010 | Economic Times (India), The

Drugmaker Lupin expects sales in emerging markets to equal sales in the U.S. and Japan, combined, by 2018. The company plans to expand operations in Brazil and Mexico, where it sees opportunity in gynecology, cardiology, oral contraceptives and biotechnology markets.

View Full Article in:

Economic Times (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI